Lombard Medical Technologies keeps the blood flowing through your veins with its cardiovascular medical devices. The company's flagship product is Aorfix, an endovascular stent graft approved in Europe for treatment of abdominal aortic aneurysms (balloon-like enlargements of the aorta in the abdomen). Lombard is pursuing approval in the US for Aorfix and expanding sales in key European markets. Though Lombard is still seeking approval for Aorfix in certain key markets, it is also busily developing a next-generation version of the device, as well as product extensions of the original. Lombard Medical was founded in 2000; investment firm Invesco hold about 40% of the company's shares.